Italia markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
252,64+5,73 (+2,32%)
Alla chiusura: 04:00PM EST
253,00 +0,36 (+0,14%)
Dopo ore: 05:03PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente246,91
Aperto245,94
Denaro245,78 x 1000
Lettera258,16 x 1000
Min-Max giorno244,90 - 253,61
Intervallo di 52 settimane181,36 - 349,84
Volume250.121
Media Volume584.075
Capitalizzazione12,854B
Beta (5 anni mensile)1,33
Rapporto PE (ttm)30,15
EPS (ttm)8,38
Prossima data utili14 feb 2023 - 20 feb 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A266,17
  • GlobeNewswire

    iVexSol® Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors

    LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) -- iVexSol Inc., a technology-based lentiviral vector (LVV) contract development and manufacturing organization (CDMO), announced $23.8 million in Series A-3 funding. New investors Bristol Myers Squibb (NYSE: BMY), Charles River Laboratories (NYSE: CRL) and Asahi Kasei Medical, a division of Asahi Kasei (NYSE: AHKSY), join existing investors which include Casdin Capital and BioLife Solutions (Nasdaq: BLFS) to close Series A financing at a total of